Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN · BSE: 531633 · Pharmaceuticals & Biotechnology · 15 announcements

Share price
₹564.70
Market cap
₹1,131 Cr
Revenue (annual)
₹671.0 Cr
Net profit (annual)
₹87.89 Cr
P/E (TTM)
11.7×Sector 47.4×
Promoter holding
49.78%+0.00% QoQ
FII holding
4.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:15 IST BSE
Dividend

Lincoln Pharmaceuticals Dividend

Lincoln Pharmaceuticals declared a final dividend of ₹1.80 per equity share for FY 2025-26. The 32nd AGM is scheduled for September 30, 2026.